Babs Carryer is a serial entrepreneur and active in multiple entrepreneurial activities. She is Adjunct Professor of Entrepreneurship at CMU, Embedded Entrepreneur for Project Olympus, working with faculty to commercialize innovations, and Innovation Advisor at the Institute for Social Innovation. Since 1994, Ms. Carryer has been president of Carryer Consulting which provides strategic business planning services to technology companies in the software and life sciences sectors. She co-founded, was past president, and still serves as Board Director of LaunchCyte, a development company with five life sciences portfolio companies. In 2009, one LaunchCyte company announced a strategic partnership with Philips, including a five figure investment, to develop a diagnostic device for sepsis; in 2010, another LaunchCyte company announced a $345M deal with Biogen to develop and commercialize a new drug for the treatment of ALS, also known as Lou Gehrig’s disease.